Can the drugs used before autologous hematopoietic stem cell transplantation have impact on CMV reactivation that results in decreased os in myeloma patients after ASCT

YÜKSEL M., CENGİZ SEVAL G., KİRCİLİ E., D, K., ÖZTÜRK C., NARLI ÖZDEMİR Z., ...Daha Fazla

45th Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation (EBMT), 24 - 27 Mart 2019

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Lokman Hekim Üniversitesi Adresli: Hayır